Reversibility of pulmonary hypertension in systemic lupus erythematosus after induction immunosuppressive therapy: An inflammatory manifestation?

Objective To evaluate the possible reversibility of PAH to a normopressoric state in SLE after induction immunosuppressive (IS) and predictors of response. Methods We retrospectively evaluated all SLE-PAH patients who underwent IS therapy at our center. PAH reversion was defined as the normalization...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lupus 2025-01, Vol.34 (1), p.18-27
Hauptverfasser:	Luppino-Assad, Ana Paula, Alves Junior, Jose Leonidas, Figueiredo Neves Yuki, Emily, Seguro, Luciana Parente Costa, Pasoto, Sandra Gofinet, Fernandes, Caio Julio Cesar dos Santos, Sobral-Alves, Juliana, Jardim, Carlos Viana Poyares, Bonfá, Eloisa, Souza, Rogerio, Borba, Eduardo F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Blood pressure Cardiac Catheterization Comparative analysis Echocardiography Female Humans Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - etiology Immunosuppressive agents Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Inflammation Lupus Erythematosus, Systemic - complications Lupus Erythematosus, Systemic - drug therapy Male Middle Aged Retrospective Studies Survival Systemic lupus erythematosus Treatment Outcome Ultrasonic imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!